Nanotechnology-Based Targeted Drug Delivery Systems for Lung CancerPrashant Kesharwani Nanotechnology-based Targeted Drug Delivery Systems for Lung Cancer is an indispensable resource that will help pharmaceutical scientists and clinical researchers design and develop novel drug delivery systems and devices for the treatment of lung cancer. As recent breakthroughs in nanomedicine are now making it possible to deliver drugs, genes and therapeutic agents to localized areas of disease to maximize clinical benefit, while also limiting unwanted side effects, this book explores promising approaches for the diagnosis and treatment of lung cancer using cutting-edge nanomedical technologies. Topics discussed include polymeric nanoparticles, solid lipid nanoparticles, liposomes, dendrimers, micelles and nanoemulsions.
|
Contents
| 1 | |
| 21 | |
3 Overexpressed Receptors and Proteins in Lung Cancer | 39 |
4 Polymeric NanoparticleBased DrugGene Delivery for Lung Cancer | 77 |
5 Solid Lipid NanoparticleBased Drug Delivery for Lung Cancer | 95 |
6 LiposomeBased Drug Delivery for Lung Cancer | 123 |
7 DendrimerBased Nanocarriers in Lung Cancer Therapy | 161 |
8 Polymeric Micelles in Management of Lung Cancer | 193 |
9 Nanoemulsions as Effective Carriers for the Treatment of Lung Cancer | 217 |
10 NanomedicineBased Inhalation Treatments for Lung Cancer | 249 |
11 Toward the Development of a Novel Diagnostic NanoImaging Platform for Lung Cancer | 269 |
12 HydrogelBased Drug Delivery for Lung Cancer | 293 |
13 Quantum DotBased Drug Delivery for Lung Cancer | 311 |
| 327 | |
Back Cover | 335 |
Other editions - View all
Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer Prashant Kesharwani No preview available - 2019 |
Common terms and phrases
acid activity aerosol agents alveoli anticancer apoptosis applications approach associated blood carcinoma carriers cell lines cell lung cancer cellular chemotherapeutic chemotherapy cisplatin Clin clinical combination compared complex conjugated Control cytotoxicity Deliv dendrimers detection developed drug delivery effect efficacy efficiency EGFR encapsulation enhanced et al evaluation expression formulation functional gene growth higher human hydrogels imaging improved increased induced inhalation inhibition kinase lipid liposomes loaded lung cancer cells mechanism metastasis method mice micelles molecular nano nanocarriers nanoemulsion nanoparticles normal novel NSCLC observed overexpressed paclitaxel particles pathway patients peptide Pharm phase polymer polymeric potential prepared properties protein pulmonary receptor reduced release Research resistance response role SCLC showed signaling siRNA SLNs solid stability stage surface targeting therapeutic therapy tion tissue toxicity treat treatment tumor cells types various vitro vivo Wang Zhang